Sukhi Thethy
Comptroller/Controller/Auditor at CHINOOK THERAPEUTICS, INC.
Sukhi Thethy active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Career history of Sukhi Thethy
Former positions of Sukhi Thethy
| Companies | Position | Start | End |
|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Training of Sukhi Thethy
| San Jose State University | Graduate Degree |
Statistics
International
| United States | 4 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Stock Market
- Insiders
- Sukhi Thethy
- Experience
